News Releases

OPTIMIZERx Announces Sponsorship of the CBInet eRx and EHR Conference

March 20, 2014 at 4:47 PM EDT

ROCHESTER, MI--(Marketwired - Mar 20, 2014) - OPTIMIZERx Corp (OTCQB: OPRX) today announced that it is sponsoring the CBInet eRx and EHR conference March 26 - 27 in Philadelphia, PA.

OPTIMIZERx is excited to be one of the lead Co-Sponsors for this inaugural event. The conference is the first and only conference dedicated entirely to strategies and tactics that leverage the ever-growing utilization of e-prescribing and EHR technology and focuses on leverage opportunities for promotional effectiveness and brand awareness. The conference will be held at the Hyatt at the Bellevue in Philadelphia, PA. Amongst the industry expert, pharmaceutical presenters and discussion panel members, David Harrell the Chairman and CEO of OPTIMIZERX will also be presenting on leveraging technology to improve patient result and outcomes.

"With the ever changing landscape and transformation of the healthcare market, we are forging a new frontier for pharmaceutical marketing and brand managers," said David Harrell, Chairman and CEO of OPTIMIZERx Corporation, "by sponsoring this event we bring together industry leading experts from manufacturers, healthcare providers and solution suppliers in one forum to share experiences, discuss issues, and collaborate to pave new roads to effectively utilize these technologies that result in better patient outcomes."

For more information and to register: http://www.cbinet.com/conference/pc14028#.UwzmRPldWSo

OPTIMIZERx Corp. provides unique consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. For more information, please go to www.optimizerxcorp.com.

'SAFE HARBOR'

This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended and such section 21E of the Securities Act of 1934, amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.